Pantolam 20 mg (Tablet (Enteric Coated))
Unit Price: ৳ 3.00
Medicine Details
Category | Details |
---|---|
Generic | Pantoprazole sodium |
Company | Orbit pharmaceuticals ltd |
Indications
- Peptic ulcer diseases
- Gastroesophageal reflux diseases
- Ulcer induced by non-steroidal anti-inflammatory drugs (NSAIDs)
- Eradication of Helicobacter pylori (in combination with antibiotics)
- Zollinger-Ellison Syndrome
Pharmacology
- Proton pump inhibitor
- Suppression of gastric acid production
- Covalent binding to the H+/K+ATPase enzyme system
- Inhibition of basal and stimulated gastric acid secretion
Dosage & Administration
- Benign gastric ulcer: 40 mg daily in the morning for 4 weeks
- Gastro-esophageal reflux disease: 20-40 mg daily in the morning for 4 weeks
- Duodenal ulcer: 40 mg daily in the morning for 2 weeks
- Duodenal ulcer associated with Helicobacter pylori: 40 mg twice daily in association with antimicrobial agents
- Prophylaxis of NSAID-associated gastric or duodenal ulcer: 20 mg daily
- Zollinger-Ellison Syndrome: Initially 80 mg once daily, adjusted according to response
- IV Injection for various conditions
Drug Interactions
No significant drug interactions observed in clinical studies
Contraindications
Pantoprazole is contraindicated in patients with known hypersensitivity to any of the components of the formulation
Side Effects
- Headache
- Diarrhea
- Abdominal pain
- Flatulence
- Rash
- Insomnia
- Hyperglycemia
Pregnancy & Lactation
- US FDA Pregnancy Category B
- No adequate and well-controlled studies in pregnant women
- Excreted in human milk, decision should be made whether to discontinue nursing or the drug
Precautions & Warnings
- Tablet should not be split, chewed or crushed
- Long-term therapy may lead to malabsorption of cyanocobalamin
- Increased risk of osteoporosis related disorders
Overdose Effects
- No known symptoms of overdosage in humans
- Not readily dialyzable
- Symptomatic and supportive management recommended
Therapeutic Class
Proton Pump Inhibitor
Reconstitution
- IV injection and IV infusion directions
- Must be given as intravenous administration only and by slow injection/infusion
Storage Conditions
Keep in a dry place, away from light and heat, out of the reach of children
Chemical Structure
- Molecular Formula: C16H15F2N3O4S
- Chemical Structure Image
Commonly Asked Questions
- Details regarding the tablet usage, improvement timeline, frequency, storage, effects on older adults, time to work, safety, weight gain, side effects, use during pregnancy or breastfeeding, missed dose
Usability
- Oral and IV administration
- Potential long-term therapy implications
- Suitable for various gastrointestinal conditions
- Caution for specific patient groups
Storage
- Dry place
- Protected from light and heat
- Keep out of the reach of children
Dosage
- Daily dosages for various conditions
- Duration of treatment
- Directions for IV administration
Chemical Composition
- Molecular Formula
- Chemical Structure
Caution
- Tablet should not be split, chewed or crushed
- Long-term therapy may lead to malabsorption of cyanocobalamin
Infusion Administration
Instructions for reconstitution and dilution for IV infusion
Reconstitution Shelf-life
- Reconstituted solution shelf-life at room temperature
- Admixed solution shelf-life at room temperature
Pregnancy Considerations
- US FDA Pregnancy Category B
- No adequate and well-controlled studies in pregnant women
- Excretion in human milk, decision-making for nursing mothers
Long-term Therapy
- Potential implications for malabsorption and osteoporosis related disorders
- Consideration for managing side effects during long-term usage
Dosage Adjustment
- Initial dose and potential for adjustment based on response
IV Injection
Directions for IV administration and reconstitution
IV Infusion
Instructions and shelf-life for IV infusion
Molecular Formula
C16H15F2N3O4S
Chemical Structure Image
Chemical Structure Image URL
Improvement Timeline
Expected improvement timeline upon using the tablet
Frequency
Dosage frequency as prescribed by the doctor
Storage & Disposal
- Instructions for proper storage and disposal
- Protection from reach of children and pets
Elderly Precautions
- Increased risk for bone fractures especially with longer use and higher doses for older adults
Symptomatic Management
Recommendation for symptomatic and supportive management in case of overdose
No Drug Interactions
Clinical studies have not shown significant drug interactions
Excretion in Human Milk
Associated considerations for nursing mothers
Related Brands
- AUP 20 mg (Tablet (Enteric Coated)) - decent-pharma-laboratories-ltd
- AUP 40 mg (Tablet (Enteric Coated)) - decent-pharma-laboratories-ltd
- Cospra 20 mg (Tablet (Enteric Coated)) - cosmo-pharma-laboratories-ltd
- Detonix 20 mg (Tablet (Enteric Coated)) - desh-pharmaceuticals-ltd
- P-Gut 20 mg (Tablet (Enteric Coated)) - globe-pharmaceuticals-ltd